Register Log-in Investor Type

News

05 Dec 2022

CT UK High Income half year report

CT UK High Income Trust (CHI) has recently released its half year report, for the six-month period ending 30 September 2022. We remind readers that CHI operates with two share classes, ordinary and B. Over the period CHI generated a NAV total return of -11.8%, compared to the -8.3% return of its benchmark, the FTSE […]

05 Dec 2022

QuotedData’s morning briefing 5 December 2022

In QuotedData’s morning briefing 5 December 2022: SME Credit Realisation Fund (SCRF) reported a disposal of the trust’s remaining US loans, which were sold to a third-party buyer. SCRF expects to receive net proceeds of c.£2.5m from the sale. As part of the managed wind-down of its operations, SCRF continues to explore opportunities for further […]

28 Nov 2022

JLEN Environmental Assets half-year results

JLEN Environmental Asset (JLEN) has reported its half year results, for the six-month period ending 30 September 2022. JLEN reported a NAV of £890.2m, equal to 125.4p per share, an increase from the £795.4m it reported on 31 March 2022. JLEN has generated a share price total return of 92.4% since its IPO, equal to […]

28 Nov 2022

QuotedData’s morning briefing 28 November 2022

In QuotedData’s morning briefing 28 November 2022: Pollen Street (POLN) has provided its Q3 update. As a reminder, POLN has formed from the merger of Honeycomb Investment Trust and Pollen Street Capital Holdings on 30 September 2022, and focuses on high quality, asset-backed senior secured lending. POLN reported a return on Net Investment Asset of […]

31 Oct 2022

Volta Finance has published its annual report

Volta Finance Limited (VTA) has reported its annual results for its financial year ending 31 July 2022. VTA reported a NAV total return of -7.3% and share price total return of -4.3%. The chairman believes these movements are broadly in line with the wider market. Over the period VTA paid a dividend of EUR 0.57 […]

31 Oct 2022

Schroder UK Public Private Trust invests in antibody drug firm

Schroder UK Public Private Trust (SUPP) has announced that it has made a commitment of CHF 3m (£2.7m) to antibody-drug conjugates (ADCs) development company, Araris Biotech AG, as part of its CHF 23.5m (£21.4m,) financing round. Araris is pioneering the development of a novel antibody-drug conjugate ADC-linker technology to enable efficient and precise production of […]

31 Oct 2022

NextEnergy Solar Fund acquired 250MW battery storage project

NextEnergy Solar Fund (NESF) has announced it has acquired the development rights, permits, and initial grid milestones for a 250MW portfolio of high-quality battery storage projects and grid connections, with the project having secured planning permission and grid connection rights. The strategic portfolio named ‘Project Lion’, located in the East of England, was acquired for […]

31 Oct 2022

Gore Street Energy Storage acquire 200MW project

Gore Street Energy Storage Fund (GSF) has announced that it has agreed to acquire from Kona Energy a 200MW construction-ready energy storage project in Heysham, North West England.  The project is one of the largest storage projects in Europe and GSF’s largest acquisition to date. With this acquisition, GSF’s portfolio will consist of 25 projects with a […]

31 Oct 2022

QuotedData’s morning briefing 31 October 2022

In QuotedData’s morning briefing for 31 October 2022: Riverstone Credit Opportunities Income (RCOI) has announced an upsize of its investment in Harland & Wolff Group Holdings PLC (“Harland & Wolff”),which focuses on strategic infrastructure projects and physical asset lifecycle management across five core industries: renewables, oil & gas, defence, cruise & ferry and commercial. In […]

24 Oct 2022

Syncona bids for retinal biotech firm AGTC

Syncona (SYNC) has announced a tender offer to acquire all outstanding shares of Applied Genetic Technologies Corporation (AGTC), for $0.34 per share, valuing AGTC at approximately $23.5m (£20.8m). There is also the potential for up to an additional $50.0m (up to $0.73 per share) in contingent value rights in the event certain milestones related to […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…